Find Paid Clinical Trials in the District of Columbia

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in District of Columbia

Top of Directory » All Locations » United States » District of Columbia


  • Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

    Condition:   Colorectal Cancer
    Interventions:   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
    Sponsors:   Lombardi Cancer Research Center;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study

    Conditions:   Obesity;   Diabetes Mellitus, Type 2;   Abnormal Glucose Metabolism;   Type 2 Diabetes
    Intervention:   Behavioral: Assignment of a Lay Patient Partner
    Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting - verified September 2009

  • Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Leukemia
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: Southern blotting;   Genetic: cytogenetic analysis;   Genetic: polymerase chain reaction
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

    Condition:   Leukemia
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)

    Condition:   Coronary Artery Disease
    Intervention:  
    Sponsor:   Medstar Research Institute
    Not yet recruiting - verified October 2009

  • Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction

    Condition:   Coronary Artery Disease
    Intervention:  
    Sponsor:   Medstar Research Institute
    Not yet recruiting - verified October 2009

  • Registry Experience at the Washington Hospital Center, DES - Xience V

    Condition:   Coronary Artery Disease
    Intervention:  
    Sponsor:   Medstar Research Institute
    Recruiting - verified October 2009

  • Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)

    Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
    Intervention:   Drug: Ofatumumab and Bendamustine
    Sponsors:   Georgetown University;   GlaxoSmithKline;   Cephalon
    Not yet recruiting - verified October 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • The Women's HIV SeroIncidence Study (ISIS)

    Condition:   HIV Infections
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified June 2009

  • Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) 2009 monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009

  • Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009

  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)

    Condition:   Atrial Fibrillation
    Interventions:   Drug: Vernakalant;   Drug: Placebo
    Sponsors:   Astellas Pharma Inc;   Cardiome Pharma
    Recruiting - verified November 2009

  • A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

    Condition:   Non-Hodgkin's Lymphoma
    Interventions:   Drug: YM155;   Biological: Rituximab
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

    Condition:   Cancer
    Intervention:   Drug: MEDI-551
    Sponsor:   MedImmune LLC
    Recruiting - verified October 2009

  • A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: PF-03463275;   Drug: Placebo
    Sponsor:   Pfizer
    Not yet recruiting - verified November 2009

  • CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: JNJ-28431754;   Drug: glimepiride
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study in Patients With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: LY2439821;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Study of Blood Samples From Newborns With Down Syndrome

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Peramivir Administered Intravenously in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Serious Influenza

    Conditions:   Cough;   Sore Throat;   Nasal Congestion;   Headache;   Fever;   Seasonal Influenza
    Interventions:   Drug: Peramivir 600mg;   Drug: Peramivir 10 mg
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • A Study in Relapse Prevention of Treatment-resistant Depression

    Condition:   Treatment Resistant Depression
    Interventions:   Drug: Olanzapine and Fluoxetine combination;   Drug: Fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis

    Condition:   Sarcoidosis
    Interventions:   Drug: golimumab;   Drug: ustekinumab;   Drug: Placebo
    Sponsor:   Centocor, Inc.
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men

    Condition:   HIV Infections
    Interventions:   Behavioral: Referral of Partners;   Behavioral: Screening for STIs and counseling;   Behavioral: Peer health care system navigators;   Behavioral: Enhanced counseling
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH);   National Institutes of Health (NIH)
    Recruiting - verified July 2009

  • Study of Patients With Advanced Non-Small Cell Lung Cancer

    Condition:   Advanced Non-Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel;   Biological: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children 6-17 Years of Age With Urea Cycle Disorders, With a Long-Term Safety Extension

    Condition:   Urea Cycle Disorders
    Intervention:   Drug: HPN-100
    Sponsor:   Hyperion Therapeutics, Inc.
    Recruiting - verified October 2009

  • A Study of LY2189102 in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes
    Interventions:   Drug: LY2189102;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

    Condition:   Breast Cancer
    Intervention:  
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   University of Chicago;   Dana-Farber Cancer Institute;   Georgetown University;   Johns Hopkins University;   M.D. Anderson Cancer Center;   University of Alabama at Birmingham;   University of California, San Francisco;   University of North Carolina;   Duke University;   Vanderbilt-Ingram Cancer Center;   The Indiana University Simon Cancer Center;   Mayo Clinic;   University of Pittsburgh;   University of Michigan Health System
    Recruiting - verified November 2009

  • An Open-Label Extension Study For SP847

    Condition:   Epilepsy
    Intervention:   Drug: Lacosamide
    Sponsor:   UCB, Inc.
    Not yet recruiting - verified November 2009

  • A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: gemcitabine/carboplatin;   Drug: gemcitabine/carboplatin plus BSI-201
    Sponsor:   BiPar Sciences
    Recruiting - verified November 2009

  • 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

    Condition:   Schizophrenia
    Interventions:   Drug: paliperidone palmitate;   Drug: oral risperidone
    Sponsor:   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified November 2009

  • Trial To Study The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

    Condition:   Epilepsy
    Interventions:   Drug: Lacosamide;   Drug: Lacosamide;   Drug: Lacosamide
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

    Condition:   Bronchiectasis
    Interventions:   Drug: Cipro (Ciprofloxacin, BAYQ3939);   Drug: Placebo
    Sponsors:   Bayer;   Novartis
    Recruiting - verified November 2009

  • A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

    Condition:   Scleroderma
    Interventions:   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546;   Drug: MEDI-546
    Sponsor:   MedImmune LLC
    Recruiting - verified October 2009

  • Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

    Condition:   Solid Tumors
    Intervention:   Drug: I-131-CLR1404
    Sponsor:   Cellectar, Inc
    Recruiting - verified November 2009

  • Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

    Conditions:   Non Small-cell Lung Cancer;   Small-cell Lung Cancer
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified March 2009

  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

    Conditions:   Chordoma;   Desmoid Tumor;   Sarcoma
    Interventions:   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

    Condition:   Brain and Central Nervous System Tumors
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of Anti-HIV Monoclonal Antibody KD-247

    Condition:   HIV Infections
    Interventions:   Drug: KD-247;   Drug: Physiological saline
    Sponsor:   The Chemo-Sero-Therapeutic Research Institute
    Recruiting - verified June 2009

  • Effect of LY2062430 on the Progression of Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: LY2062430;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

    Condition:   Neuroblastoma
    Interventions:   Genetic: loss of heterozygosity analysis;   Other: cytology specimen collection procedure;   Procedure: biopsy
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Kidney Tumors in Young Patients

    Conditions:   Kidney Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

    Conditions:   Leukemia;   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

    Condition:   Sarcoma
    Interventions:   Other: biologic sample preservation procedure;   Other: medical chart review
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes

    Conditions:   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials